Literature DB >> 20159366

Equivalence in dose fall-off for isocentric and nonisocentric intracranial treatment modalities and its impact on dose fractionation schemes.

Lijun Ma1, Arjun Sahgal, Martina Descovich, Young-Bin Cho, Cynthia Chuang, Kim Huang, Normand J Laperriere, Dennis C Shrieve, David A Larson.   

Abstract

PURPOSE: To investigate whether dose fall-off characteristics would be significantly different among intracranial radiosurgery modalities and the influence of these characteristics on fractionation schemes in terms of normal tissue sparing. METHODS AND MATERIALS: An analytic model was developed to measure dose fall-off characteristics near the target independent of treatment modalities. Variations in the peripheral dose fall-off characteristics were then examined and compared for intracranial tumors treated with Gamma Knife, Cyberknife, or Novalis LINAC-based system. Equivalent uniform biologic effective dose (EUBED) for the normal brain tissue was calculated. Functional dependence of the normal brain EUBED on varying numbers of fractions (1 to 30) was studied for the three modalities.
RESULTS: The derived model fitted remarkably well for all the cases (R(2) > 0.99). No statistically significant differences in the dose fall-off relationships were found between the three modalities. Based on the extent of variations in the dose fall-off curves, normal brain EUBED was found to decrease with increasing number of fractions for the targets, with alpha/beta ranging from 10 to 20. This decrease was most pronounced for hypofractionated treatments with fewer than 10 fractions. Additionally, EUBED was found to increase slightly with increasing number of fractions for targets with alpha/beta ranging from 2 to 5.
CONCLUSION: Nearly identical dose fall-off characteristics were found for the Gamma Knife, Cyberknife, and Novalis systems. Based on EUBED calculations, normal brain sparing was found to favor hypofractionated treatments for fast-growing tumors with alpha/beta ranging from 10 to 20 and single fraction treatment for abnormal tissues with low alpha/beta values such as alpha/beta = 2. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20159366     DOI: 10.1016/j.ijrobp.2009.07.1721

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

Review 1.  Stereotactic radiosurgery alone for multiple brain metastases? A review of clinical and technical issues.

Authors:  Arjun Sahgal; Mark Ruschin; Lijun Ma; Wilko Verbakel; David Larson; Paul D Brown
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

2.  Treatment Planning for Self-Shielded Radiosurgery.

Authors:  John R Adler; Achim Schweikard; Younes Achkire; Oliver Blanck; Mohan Bodduluri; Lijun Ma; Hui Zhang
Journal:  Cureus       Date:  2017-09-08

3.  Correlation between small-volume spinal cord doses for spine stereotactic body radiotherapy (SBRT).

Authors:  Lijun Ma; Lei Wang; Young Lee; Chia-Lin Tseng; Scott Soltys; Steve Braunstein; Arjun Sahgal
Journal:  J Radiosurg SBRT       Date:  2018

4.  Whole-procedural radiological accuracy for delivering multi-session gamma knife radiosurgery with a relocatable frame system.

Authors:  Lijun Ma; Dilini Pinnaduwage; Michael McDermott; Penny K Sneed
Journal:  Technol Cancer Res Treat       Date:  2013-08-31

5.  Dose Evaluation of Fractionated Schema and Distance From Tumor to Spinal Cord for Spinal SBRT with Simultaneous Integrated Boost: A Preliminary Study.

Authors:  Hao Yang; Bo-ning Cai; Xiao-shen Wang; Xiao-hu Cong; Wei Xu; Jin-yuan Wang; Jun Yang; Shou-ping Xu; Zhong-jian Ju; Lin Ma
Journal:  Med Sci Monit       Date:  2016-02-23

6.  Comparing gamma knife and cyberknife in patients with brain metastases.

Authors:  Terence T Sio; Sunyoung Jang; Sung-Woo Lee; Bruce Curran; Anil P Pyakuryal; Edward S Sternick
Journal:  J Appl Clin Med Phys       Date:  2014-01-06       Impact factor: 2.102

7.  Cyberknife Dosimetric Planning Using a Dose-Limiting Shell Method for Brain Metastases.

Authors:  Kyoung Jun Yoon; Byungchul Cho; Jung Won Kwak; Doheui Lee; Do Hoon Kwon; Seung Do Ahn; Sang-Wook Lee; Chang Jin Kim; Sung Woo Roh; Young Hyun Cho
Journal:  J Korean Neurosurg Soc       Date:  2018-10-30

Review 8.  Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.

Authors:  Michael T Milano; Jimm Grimm; Andrzej Niemierko; Scott G Soltys; Vitali Moiseenko; Kristin J Redmond; Ellen Yorke; Arjun Sahgal; Jinyu Xue; Anand Mahadevan; Alexander Muacevic; Lawrence B Marks; Lawrence R Kleinberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-09-11       Impact factor: 8.013

9.  Variable dose interplay effects across radiosurgical apparatus in treating multiple brain metastases.

Authors:  Lijun Ma; Alan Nichol; Sabbir Hossain; Brian Wang; Paula Petti; Rosemin Vellani; Chris Higby; Salahuddin Ahmad; Igor Barani; Dennis C Shrieve; David A Larson; Arjun Sahgal
Journal:  Int J Comput Assist Radiol Surg       Date:  2014-04-20       Impact factor: 2.924

10.  The impact of CyberKnife's prescription isodose percentage on intracranial target planning.

Authors:  Sung-Woo Lee; Sunyoung Jang; Anil P Pyakuryal; Kenneth Chang; Terence T Sio
Journal:  J Appl Clin Med Phys       Date:  2014-09-08       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.